High-risk human papillomavirus (HR-HPV) infection is a leading cause of cervical cancer, of which human papillomavirus (HPV)-16 and HPV-18 account for about 70% of cases. Since HPV infection is common, it is important to focus on the HPV genotypes that pose the highest risk for effective cervical cancer screening. In this study, we evaluated the clinical usefulness of HPV-16/HPV-18 genotyping for cervical cancer screening.

中文翻译：

---

HPV-16 和 HPV-18 基因分型对宫颈癌筛查的临床实用性评估。

高危人乳头瘤病毒（HR-HPV）感染是宫颈癌的主要原因，其中人乳头瘤病毒（HPV）-16和HPV-18约占宫颈癌病例的70%。由于 HPV 感染很常见，因此重要的是要关注对有效宫颈癌筛查构成最高风险的 HPV 基因型。在这项研究中，我们评估了 HPV-16/HPV-18 基因分型在宫颈癌筛查中的临床实用性。